Stay updated on Nivolumab for Uterine Cancer - Clinical Trial
Sign up to get notified when there's something new on the Nivolumab for Uterine Cancer - Clinical Trial page.

Latest updates to the Nivolumab for Uterine Cancer - Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedAdded a new Locations section listing trial sites by state (New Jersey, New York, Pennsylvania). Removed the HHS Vulnerability Disclosure link from the footer.SummaryDifference0.4%

- Check27 days agoNo Change Detected
- Check49 days agoChange DetectedPublications section now states entries are automatically filled from PubMed and may not all be about the study. The page revision is updated to v3.3.2, and the previous PubMed description and v3.2.0 revision have been removed.SummaryDifference0.1%

- Check56 days agoChange DetectedRemoved the site-wide notice about government funding and NIH operations; core study details and links remain unchanged.SummaryDifference0.4%

- Check70 days agoChange DetectedNo additions or deletions were detected between the two screenshots. The page content remains unchanged.SummaryDifference0.4%

- Check98 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference4%

- Check106 days agoChange DetectedUpdated medical term from Endometrioid stromal sarcoma to Endometrial stromal sarcoma and bumped revision from v3.0.2 to v3.1.0.SummaryDifference0.2%

Stay in the know with updates to Nivolumab for Uterine Cancer - Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab for Uterine Cancer - Clinical Trial page.